BCS - Barclays PLC
NYSE
->
Financial Services
->
Banks—Diversified
London,
United Kingdom
Type: Equity
BCS price evolution
BCS
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $3650 | $3417 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1576634 | $1577118 | $1477487 | $1591721 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $197620 | $176102 | $136214 | $171020 |
| Long term debt | $108567 | $118790 | $107319 | $114014 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1505461 | $1505438 | $1406283 | $1523406 |
| Shareholders' equity | ||||
| Retained earnings | $55803 | $54137 | $55059 | $52201 |
| Other shareholder equity | $12749 | $13241 | $13223 | $11857 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 23 Feb 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $240312 | $193690 | ||
| Short term investments | $798314.61 | $705517.74 | $664355.89 | $146647 |
| Net receivables | $261 | $477 | ||
| Inventory | ||||
| Total current assets | $1500006.63 | $1462022.1 | $1354363.63 | $907039 |
| Long term investments | $33021.35 | $29549.64 | $24805.99 | $85934 |
| Property, plant & equipment | $3415 | $3611 | $3541.86 | $4026 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1477487 | $1513699 | $1379169.63 | $1349514 |
| Current liabilities | ||||
| Accounts payable | $6638 | $7870 | $548679 | $502742 |
| Deferred revenue | ||||
| Short long term debt | $154518.13 | $122486.92 | $111213.51 | $35797 |
| Total current liabilities | $187646 | $71591 | $1296723.42 | $1155939 |
| Long term debt | $67811 | $66997 | $138581 | $120947 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1406283 | $1445407 | $1310203.42 | $1282632 |
| Shareholders' equity | ||||
| Retained earnings | $55059 | $54658 | $50469.81 | $45527 |
| Other shareholder equity | $13223 | $10821 | $14029 | $15633 |
| Total shareholder equity | $73880.67 | $67293.71 | $68966.2 | $65797 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 15 Feb 2023 | 31 Jan 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $29106 | $35984.18 | $17060 | |
| Cost of revenue | $1202.17 | |||
| Gross Profit | $34782.01 | $17060 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2410.24 | $13437 | ||
| Total operating expenses | $29080.59 | $13437 | ||
| Operating income | $6903.59 | $3623 | ||
| Income from continuing operations | ||||
| EBIT | $6909.5 | |||
| Income tax expense | $1234 | $1023.81 | $604 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $4274 | $4949.57 | $2383 | |
| Income (for common shares) | $4949.57 | $1526 | ||
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$16333 | -$23414 | -$14784 | -$21673 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $166 | -$1389 | -$191 | $696 |
| Effect of exchange rate | -$1624 | -$5053 | -$6069 | $10330 |
| Change in cash and equivalents | $19779 | -$30783 | $2867 | $19584 |
| (in millions $) | 31 Jan 2024 | 15 Feb 2023 | 23 Feb 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $4949.57 | $6351.44 | $2383 | |
| Operating activities | ||||
| Depreciation | $1759.89 | $2068.33 | $718 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $29789.08 | $48738.23 | -$1435 | |
| Investing activities | ||||
| Capital expenditures | -$1720.48 | -$1713.64 | -$1324 | |
| Investments | -$17040 | |||
| Total cash flows from investing | -$23414 | -$21356.18 | $4254.22 | -$18376 |
| Financing activities | ||||
| Dividends paid | -$2259 | -$857 | ||
| Sale and purchase of stock | ||||
| Net borrowings | -$974782.24 | -$913257.71 | $3916 | |
| Total cash flows from financing | -$1389 | $685.83 | $106.6 | $61672 |
| Effect of exchange rate | -$5053 | $1668 | ||
| Change in cash and equivalents | -$30783 | -$435.23 | $35693.09 | $43529 |
News
Fundamentals
| Market cap | $89.96B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 3.55B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 19.03 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |